Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-25 Purchase |
2025-02-27 6:51 pm |
Septerna Inc. | SEPN | Labrucherie Gil M Chief Financial Officer |
10,000 | $5.6867 | $56,867 | 40,000 (Indirect) |
View |
| 2025-02-19 Purchase |
2025-02-21 6:06 pm |
Septerna Inc. | SEPN | Labrucherie Gil M Chief Financial Officer |
30,000 | $5.7432 | $172,297 | 30,000 (Indirect) |
View |
| 2022-05-16 Sale |
2022-05-17 9:32 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
17,448 | $3.95 | $68,920 | 312,905 (Direct) |
View |
| 2022-05-04 Purchase(A) |
2022-05-09 4:28 pm |
Rezolute Inc. | RZLT | Labrucherie Gil M Director |
52,631 | $3.8 | $199,998 | 53,572 (Indirect) |
View |
| 2022-05-04 Purchase |
2022-05-06 5:15 pm |
Rezolute Inc. | RZLT | Labrucherie Gil M Director |
52,631 | $3.8 | $199,998 | 99,673 (Indirect Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 6:14 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,579 | $10.95 | $82,990 | 301,603 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 6:06 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
24,149 | $13.1 | $316,391 | 256,682 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 6:58 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
10,867 | $13.76 | $149,481 | 240,231 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,898 | $18.3 | $144,533 | 251,098 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:03 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,977 | $22.37 | $178,445 | 258,996 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-04 8:42 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
150,000 | $19.86 | $2,979,629 | 341,973 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:03 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
8,276 | $16.93 | $140,113 | 226,973 (Direct) |
View |
| 2020-09-17 Sale |
2020-09-21 8:59 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
2,000 | $19.96 | $39,920 | 235,249 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 6:37 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
8,245 | $19.67 | $162,199 | 237,249 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-20 6:29 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,727 | $22.54 | $174,155 | 245,494 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-16 Option Award |
2025-02-20 11:10 am |
N/A 2035-02-16 |
Rezolute Inc. | RZLT | Labrucherie Gil M Director |
40,500 | $0 | 94,072 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-07 4:37 pm |
N/A 2035-02-06 |
Septerna Inc. | SEPN | Labrucherie Gil M Chief Financial Officer |
222,000 | $0 | 222,000 (Direct) |
View |
| 2024-08-31 Option Award |
2024-09-04 8:36 pm |
N/A 2034-08-30 |
ACELYRIN Inc. | SLRN | Labrucherie Gil M CFO and CBO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 6:59 pm |
N/A 2034-05-22 |
ACELYRIN Inc. | SLRN | Labrucherie Gil M CFO and CBO |
184,042 | $0 | 184,042 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 12:08 pm |
N/A 2034-01-23 |
Rezolute Inc. | RZLT | Labrucherie Gil M Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-11 6:26 pm |
N/A 2034-01-08 |
ACELYRIN Inc. | SLRN | Labrucherie Gil M Chief Financial Officer |
855,513 | $0 | 855,513 (Direct) |
View |
| 2023-10-04 Other |
2023-10-06 5:53 pm |
N/A N/A |
ACELYRIN Inc. | SLRN | Labrucherie Gil M Chief Financial Officer |
40,763 | $0 | 87,776 (Indirect) |
View |
| 2023-08-17 Option Award |
2023-08-21 4:48 pm |
N/A 2033-08-16 |
ACELYRIN Inc. | SLRN | Labrucherie Gil M Chief Financial Officer |
254,939 | $0 | 261,189 (Direct) |
View |
Ownership |
2023-08-03 8:08 pm |
N/A N/A |
ACELYRIN Inc. | SLRN | Labrucherie Gil M Interim CFO |
0 | $0 | 6,250 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 5:43 pm |
N/A 2032-06-23 |
Rezolute Inc. | RZLT | Labrucherie Gil M Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-15 Option Award |
2022-05-17 9:32 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
28,750 | $0 | 312,905 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-20 8:23 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
146,950 | $0 | 403,182 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 6:04 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
40,150 | $0 | 280,831 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-14 9:05 pm |
N/A 2027-12-11 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
71,550 | $0 | 71,550 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-14 9:03 pm |
N/A 2031-06-14 |
Rezolute Inc. | RZLT | Labrucherie Gil M Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 8:42 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
125,000 | $8.8 | 341,973 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 8:42 pm |
2017-02-06 2021-02-05 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
150,000 | $0 | 341,973 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:48 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
111,500 | $0 | 338,473 (Direct) |
View |